These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31677525)

  • 1. Generation of a WWTR1 mutation induced pluripotent stem cell line, MUSIi012-A-1, using CRISPR/Cas9.
    Lorthongpanich C; Jiamvoraphong N; Supakun P; Damkham N; Terbto P; Waeteekul S; U-Pratya Y; Laowtammathron C; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101634. PubMed ID: 31677525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
    Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a PDX1-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system.
    Lee Y; Choi HY; Kwon A; Park H; Park MH; Kim JW; Kim MJ; Kim YO; Kwak S; Koo SK
    Stem Cell Res; 2019 Dec; 41():101632. PubMed ID: 31683099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of RUNX1c-eGFP induced pluripotent stem cell, MUSIi012-A-4, using CRISPR/Cas9.
    Srisook P; Laowtammathron C; Lorthongpanich C; Klaihmon P; Terbto P; Waeteekul S; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2023 Mar; 67():103035. PubMed ID: 36753833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP-depleted iPSC MUSIi012-A-2 maintained all normal stem cell characteristics.
    Lorthongpanich C; Laowtammathron C; Jiamvoraphong N; Srisook P; Chingsuwanrote P; Klaihmon P; Damkham N; Terbto P; Waeteekul S; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2020 Mar; 43():101723. PubMed ID: 32018207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing.
    Feng H; Li Q; Margolis RL; Li PP
    Stem Cell Res; 2021 May; 53():102346. PubMed ID: 34087983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9.
    Yuan F; Guo D; Liu Y; Xu Y; Gao G; Wu Y; Yang F; Ke X; Lai K; Wei H; Li YX
    Stem Cell Res; 2018 Jan; 26():67-71. PubMed ID: 29247816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing.
    Zhao H; He L; Huang H; Li S; Cheng N; Tang F; Han X; Lin Z; Huang R; Zhou P; Deng S; Huang J; Li Z
    Stem Cell Res; 2020 Oct; 48():102003. PubMed ID: 32977294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
    Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing.
    Lilianty J; Nur Patria Y; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
    Stem Cell Res; 2020 May; 45():101843. PubMed ID: 32446218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing.
    Getachew A; Yang Z; Huang X; Wu F; Liu YY; Yan C; Yang F; Li Y
    Stem Cell Res; 2021 Jul; 54():102401. PubMed ID: 34058685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a homozygous ARHGAP11B knockout hiPSC line by CRISPR/Cas9 system.
    Liu Y; Jin Y; Chen T; Wu Y; Peng X; Li W; Wei S; Chen M; Zou Q; Guo S; Xu J; Tang C; Zhou X
    Stem Cell Res; 2022 May; 61():102764. PubMed ID: 35358830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two compound heterozygous HGSNAT-mutated lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo C syndrome.
    Benetó N; Cozar M; García-Morant M; Creus-Bachiller E; Vilageliu L; Grinberg D; Canals I
    Stem Cell Res; 2019 Dec; 41():101616. PubMed ID: 31731183
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell type-specific YAP1-WWTR1/TAZ transcriptional responses after autophagy perturbations are determined by levels of α-catenins (CTNNA1 and CTNNA3).
    Pavel M; Park SJ; Tanasa R; Rubinsztein DC
    Autophagy; 2021 Jul; 17(7):1788-1790. PubMed ID: 34036899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology.
    Fulgencio-Covián A; Álvarez M; Pepers BA; López-Márquez A; Ugarte M; Pérez B; van Roon-Mom WMC; Desviat LR; Richard E
    Stem Cell Res; 2020 Dec; 49():102055. PubMed ID: 33128956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing.
    Bogomiakova ME; Sekretova EK; Eremeev AV; Shuvalova LD; Bobrovsky PA; Zerkalenkova EA; Lebedeva OS; Lagarkova MA
    Stem Cell Res; 2021 Aug; 55():102451. PubMed ID: 34237591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.
    Kim SH; Basili T; Dopeso H; Da Cruz Paula A; Bi R; Issa Bhaloo S; Pareja F; Li Q; da Silva EM; Zhu Y; Hoang T; Selenica P; Murali R; Chan E; Wu M; Derakhshan F; Maroldi A; Hanlon E; Ferreira CG; Lapa E Silva JR; Abu-Rustum NR; Zamarin D; Chandarlapaty S; Matrai C; Yoon JY; Reis-Filho JS; Park KJ; Weigelt B
    J Pathol; 2022 Aug; 257(5):635-649. PubMed ID: 35411948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a human induced pluripotent stem cell line with Cas9 driven by Tet-on operator via AAVS1 safe harbor gene-editing.
    Ding Y; Wang L; Ji W; Chen Z; Wang D; Chen C; Tong H; Han Z; Niu C; Chu M; Huang J; Guo X
    Stem Cell Res; 2020 Dec; 49():102064. PubMed ID: 33207306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of NERCe003-A-3, a p53 compound heterozygous mutation human embryonic stem cell line, by CRISPR/Cas9 editing.
    Li Y; Huang C; Zha L; Kong M; Yang Q; Zhu Y; Peng Y; Ouyang Q; Lu G; Lin G; Zhou D
    Stem Cell Res; 2019 Jan; 34():101371. PubMed ID: 30658254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.